| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.36 | 0.03 |